VVRTXVertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc

VRTX

$508.75+2.06%

End of day · as of Oct 15, 2026, 5:17 PM ET

1D · 1W · 1M · 3M · YTD · 1Y · 5Y · AllLive VRTX chart
  • Mkt cap

    $106.87B

  • EV/Sales

    N/A

  • P/E ratio

    29.6

  • FY2025 Revenue

    $12.00B

  • EPS (TTM)

    $17.17

  • Gross Margin (FY2025)

    86.24%

  • Profit Margin (FY2025)

    32.94%

  • Beta

    0.43

  • Div yield

    N/A

  • Sector

    Healthcare

No recent filings in cache.

VRTX — Vertex Pharmaceuticals Inc · P/E 30, rev $12.00B

VRTX Key Statistics

  • Market Cap: $106.87B
  • P/E Ratio: 29.6
  • Previous Close: $498.50
  • Volume: 2,237,680
  • Day Range: $508.75 – $514.91

Vertex Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full VRTX income, balance, and cash tables.

  • Revenue$12.00B
  • Net Income$3.95B

VRTX FAQ

What industry is VRTX in?

Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company in the Healthcare sector.

What are VRTX's latest revenue and net income?

Latest cached Vertex Pharmaceuticals Inc (VRTX) revenue for Dec 31, 2025 was $12.00B. Net income was $3.95B. Statements: https://lician.com/financials/vrtx

What is VRTX's P/E ratio?

Vertex Pharmaceuticals Inc (VRTX) trailing P/E is 29.6 on the latest cached fundamentals snapshot.

What is VRTX's market cap?

Vertex Pharmaceuticals Inc (VRTX) market capitalization is $106.87B on the latest cached snapshot.

What are VRTX's previous close, day range, and volume?

Vertex Pharmaceuticals Inc (VRTX) cached previous close $498.50; day range $508.75 – $514.91; volume 2,237,680. Session quote: https://lician.com/quote/vrtx

Live VRTX terminal loads when you scroll near this section.